H20.82

Clinical Causes: Autoimmune response where the immune system mistakenly targets melanocytes (cells producing melanin). Genetic predispositions that may increase susceptibility. Environmental factors triggering immune reactions in susceptible individuals. Potential links to viral infections, though definitive causes are not fully understood.

Key Symptoms: Ocular symptoms such as blurred vision, floaters, and sensitivity to light. Skin manifestations including vitiligo (patches of depigmentation), alopecia (hair loss), and changes in skin pigmentation. Neurological symptoms like headaches, confusion, or dizziness. Auditory symptoms such as ringing in the ears. Other systemic signs including fever, exhaustion, or pain in various parts of the body.

Diagnosis Path: Diagnosis of Vogt-Koyanagi syndrome involves a combination of clinical evaluation, patient history, and specialized tests. Eye examinations may reveal inflammatory changes in the uveal tract. Additional tests can include blood work to detect inflammation, imaging studies like MRI scans to assess neurological involvement, and skin examinations for depigmentation. Since symptoms can mimic other conditions, a comprehensive assessment by a multidisciplinary team is often necessary to arrive at an accurate diagnosis.

Treatment Protocols: Managing Vogt-Koyanagi syndrome typically involves suppressing the immune response with corticosteroids to reduce inflammation. Immunosuppressive medications such as cyclosporine or azathioprine may be prescribed for long-term control. In cases of eye inflammation or complications, topical or systemic therapies are utilized. Regular monitoring is essential to detect and treat any recurrences or complications early. Supportive care, including visual aids or dermatological treatments, may also be recommended to improve quality of life.